hba1c

  1. forestglip

    Sociodemographic factors, biomarkers and comorbidities associated with post-acute COVID-19 sequelae in UK Biobank, 2025, Alcalde-Herraiz et al

    Sociodemographic factors, biomarkers and comorbidities associated with post-acute COVID-19 sequelae in UK Biobank Marta Alcalde-Herraiz, Shahed Iqbal, Jeffrey J. Wallin, Yunhao Liu, Wildaliz Nieves, Mark Berry, Marti Catala, Daniel Prieto-Alhambra & Junqing Xie [Line breaks added] Abstract...
  2. SNT Gatchaman

    Association of glycemic control with Long COVID in patients with type 2 diabetes: findings from the National COVID Cohort Collaborative, 2025, Soff+

    Association of glycemic control with Long COVID in patients with type 2 diabetes: findings from the National COVID Cohort Collaborative N3C Samuel Soff, Yun Jae Yoo, Carolyn Bramante, Jane E B Reusch, Jared Davis Huling, Margaret A Hall, Daniel Brannock, Til Sturmer, Zachary Butzin-Dozier...
  3. forestglip

    HbA1c and leukocyte mtDNA levels as major factors associated with post-COVID-19 syndrome in type 2 diabetes patients, 2024, Matviichuk et al

    HbA1c and leukocyte mtDNA levels as major factors associated with post-COVID-19 syndrome in type 2 diabetes patients Anton Matviichuk, Viktoriia Yerokhovych, Yeva Ilkiv, Dmytro Krasnienkov, Veronika Korcheva, Oleksandr Gurbych, Anna Shcherbakova, Pavlina Botsun, Tetyana Falalyeyeva, Oksana...
  4. T

    Fructosamine as a better marker of insulin resistance?

    After the really interesting recent study by @Chris Ponting showing some markers of insulin resistance in ME patients, the question arises, why would the HbA1c not be indicating insulin resistance in these patients? I have seen Continuous Glucose Monitor (CGM) charts of people with ME, and...
  5. leokitten

    Long-Term Effects of Novel Continuous Remote Care Intervention Including Nutritional Ketosis for Diabetes. Athinarayanan et al. Front Endocrinol 2019

    Full title: Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial. Athinarayanan et al. Front Endocrinol (2019)
Back
Top Bottom